These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256 [TBL] [Abstract][Full Text] [Related]
5. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis]. Shimoya K; Ohnishi A; Hashimoto T; Yuki N Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections. Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613 [TBL] [Abstract][Full Text] [Related]
7. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257 [TBL] [Abstract][Full Text] [Related]
8. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome. Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756 [TBL] [Abstract][Full Text] [Related]
10. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
11. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy. Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769 [TBL] [Abstract][Full Text] [Related]
13. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA. Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046 [TBL] [Abstract][Full Text] [Related]
14. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. Kaida K; Ariga T; Yu RK Glycobiology; 2009 Jul; 19(7):676-92. PubMed ID: 19240270 [TBL] [Abstract][Full Text] [Related]
15. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay. Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155 [TBL] [Abstract][Full Text] [Related]
16. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Jacobs BC; Rothbarth PH; van der Meché FG; Herbrink P; Schmitz PI; de Klerk MA; van Doorn PA Neurology; 1998 Oct; 51(4):1110-5. PubMed ID: 9781538 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
18. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. Nobile-Orazio E; Giannotta C; Briani C J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388 [TBL] [Abstract][Full Text] [Related]
19. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337 [TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I J Neuroimmunol; 2001 Feb; 113(2):260-7. PubMed ID: 11164910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]